Kinaxis (OTCMKTS:KXSCF) Reaches New 1-Year High – Should You Buy?

Kinaxis Inc. (OTCMKTS:KXSCF – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday. The company traded as high as $131.37 and last traded at $131.37, with a volume of 319 shares trading hands. The stock had previously closed at $130.77.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on KXSCF shares. BMO Capital Markets restated an “outperform” rating on shares of Kinaxis in a research note on Tuesday, August 4th. Canadian Imperial Bank of Commerce reiterated an “outperform” rating on shares of Kinaxis in a report on Monday, July 20th. Four investment analysts have rated the stock with a Buy rating. According to MarketBeat, Kinaxis presently has an average rating of “Buy”.

Read Our Latest Research Report on KXSCF

Kinaxis Stock Up 0.5%

The business has a 50-day moving average of $125.28 and a 200-day moving average of $114.01. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.88 and a current ratio of 1.88. The stock has a market capitalization of $3.56 billion and a price-to-earnings ratio of 52.97.

About Kinaxis

(Get Free Report)

Kinaxis Inc is a Canadian supply chain management software company that provides cloud-based solutions for planning, monitoring and orchestrating complex supply chain operations. Its platform is designed to help organizations improve visibility, coordinate activities across suppliers and production networks, and respond more quickly to changes in demand, supply and other operating conditions.

The company’s primary offering, Kinaxis Maestro, formerly known as RapidResponse, supports concurrent planning across areas such as demand and supply planning, inventory management, production, sales and operations planning, and supply chain control-tower operations.

Recommended Stories

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.